BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹303 Cr | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr |
What is the latest Revenue of BAL PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹303 Cr |
| Mar2024 | ₹339 Cr |
| Mar2023 | ₹304 Cr |
| Mar2022 | ₹281 Cr |
| Mar2021 | ₹251 Cr |
How is Revenue of BAL PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹303 Cr | -10.65 | |
| Mar2024 | ₹339 Cr | 11.51 | |
| Mar2023 | ₹304 Cr | 8.18 | |
| Mar2022 | ₹281 Cr | 12.25 | |
| Mar2021 | ₹251 Cr | - | |
Compare Revenue of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹121.2 Cr | -2.9% | 12% | -26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.9% |
12% |
-26% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses